Apheresis in Hematologic and Oncologic Disease
作者:
CohenRichard J.,
期刊:
Hospital Practice
(Taylor Available online 1983)
卷期:
Volume 18,
issue 10
页码: 199-205
ISSN:2154-8331
年代: 1983
DOI:10.1080/21548331.1983.11702670
出版商: Taylor&Francis
数据来源: Taylor
摘要:
Therapeutic bloodletting dates back to ancient times. With the development of sophisticated in vivo cell separators, it has become an established and effective modality in the treatment of a number of hematologic-oncologic diseases. Apheresis must, however, be used with discrimination—only when more conservative measures have proved inadequate.
点击下载:
PDF (8607KB)
返 回